Link label
Mitragynine Half-Life: How Long Does It Stay in Your Body?
Understanding the mitragynine half-life helps explain how the primary alkaloid in kratom is absorbed, processed, and eliminated from the human body. Mitragynine is the most abundant naturally occurring alkaloid in Mitragyna speciosa, commonly known as kratom. Its elimination depends on several pharmacokinetic factors, including metabolism, exposure level, frequency of consumption, and individual biological differences. Although research is developing, human studies indicate that mitragynine can remain measurable for an extended period.
Our most popular options right now, ready to ship.
In this guide
What Is the Half-Life of Mitragynine?
Mitragynine Pharmacokinetics and Elimination
Does Repeated Kratom Consumption Affect Half-Life?
Mitragynine vs. 7-Hydroxymitragynine Half-Life
What Factors Influence Mitragynine Elimination?
Research Limitations and What We Know
Compare our collections
Frequently asked questions
What Is the Half-Life of Mitragynine?
The elimination half-life describes the time required for the concentration of a substance in blood plasma to decrease by approximately 50%. Mitragynine's half-life is variable rather than a fixed number. Earlier human research reported an average elimination half-life of approximately 23 hours, while newer controlled studies have reported longer estimates depending on the preparation and exposure.
A 2024 human pharmacokinetic study investigating dried kratom leaf powder reported mean mitragynine half-life values reaching 43.4 hours after a single administration and 67.9 hours following repeated daily administration in the highest exposure group. These findings demonstrate why a single estimate cannot represent every kratom preparation or individual.
Mitragynine Pharmacokinetics and Elimination
Mitragynine pharmacokinetics describes how the alkaloid moves through the body after oral kratom consumption. Researchers evaluate plasma concentration, absorption, distribution, metabolism, and elimination to understand its concentration-time profile.
Absorption and Plasma Concentration
Following oral kratom absorption, mitragynine enters the bloodstream and reaches its maximum plasma concentration, known as Cmax. The time required to reach this peak is called Tmax. In the 2024 dried-leaf study, median Tmax generally ranged from approximately 1 to 1.7 hours.
Researchers also measure AUC (area under the curve), which represents overall drug exposure over time. These measurements help evaluate mitragynine bioavailability and compare single-dose and multiple-dose pharmacokinetics.
Metabolism and Elimination Rate
Mitragynine undergoes hepatic metabolism, producing several metabolites, including 7-hydroxymitragynine. Oxidative metabolism, liver enzymes, and glucuronidation are relevant research areas. CYP3A4, CYP2D6, and CYP2C9 are also investigated in relation to kratom alkaloid metabolism and potential drug interactions.
The body eliminates mitragynine through metabolic pathways and urinary excretion. However, the amount of unchanged mitragynine recovered in urine is not necessarily representative of total alkaloid elimination because metabolites are also involved.
Does Repeated Kratom Consumption Affect Half-Life?
Human research suggests that repeated exposure can influence mitragynine accumulation and steady-state concentration. In the 2024 study, steady-state mitragynine concentrations were reached after approximately 8–9 days of daily administration under the study conditions.
A separate 2026 human study of concentrated kratom extract also reported dose-dependent differences in mitragynine elimination half-life. These findings highlight the importance of distinguishing single-dose mitragynine half-life from multiple-dose pharmacokinetics.
Mitragynine vs. 7-Hydroxymitragynine Half-Life
Mitragynine and 7-hydroxymitragynine are distinct kratom alkaloids with different pharmacokinetic profiles. The latter is also produced through mitragynine metabolism. Its elimination half-life can differ considerably from that of its parent compound, so their plasma concentrations and detection windows should not be treated as interchangeable.
What Factors Influence Mitragynine Elimination?
Several factors may influence mitragynine clearance, including the amount of alkaloid consumed, frequency of exposure, product composition, liver metabolism, individual enzyme activity, and other substances that affect metabolic pathways. Kratom tea, dried leaf powder, and concentrated extracts may also produce different exposure profiles.
For product information, explore our Green Vein Kratom, Red Vein Kratom, White Vein Kratom, and Kratom Variety Packs. Visit Canuck Kratom to explore our product collections.
Research Limitations and What We Know
Human pharmacokinetic research remains limited, and study results depend on sample size, analytical methods, administration protocols, and product composition. LC-MS/MS analysis helps researchers measure mitragynine and its metabolites in plasma with greater precision. However, a measured plasma half-life does not establish an exact detection window or predict how long effects last. More independent clinical studies are needed to understand individual variability and long-term elimination patterns.
Important: Kratom can cause adverse effects and interact with medications. Half-life estimates are not medical guidance or a guarantee of safety.
Compare our collections
Not sure where to start? Here is what each collection includes.
Frequently asked questions
What is the half-life of mitragynine?
Mitragynine has a variable elimination half-life. Human studies have reported estimates ranging from approximately 23 hours to over 60 hours, depending on the study conditions, preparation, and exposure level.
How long does mitragynine stay in the body?
Mitragynine may remain measurable in the body for several days, depending on exposure, metabolism, individual differences, and the analytical detection method. Its half-life does not establish an exact detection window.
Does repeated kratom consumption affect mitragynine half-life?
Human pharmacokinetic research suggests repeated administration can influence mitragynine accumulation, plasma concentrations, and measured elimination half-life.
What is the difference between mitragynine and 7-hydroxymitragynine half-life?
Mitragynine and 7-hydroxymitragynine have different metabolic and elimination profiles. The latter is both a naturally occurring kratom alkaloid and a metabolite of mitragynine.
How is mitragynine eliminated from the body?
Mitragynine undergoes hepatic metabolism, producing several metabolites that are eliminated through metabolic and urinary pathways. Only a small proportion may be excreted as unchanged mitragynine.
Does kratom extract have the same pharmacokinetics as kratom powder?
No. Concentrated extracts, dried leaf powder, and kratom tea can produce different mitragynine exposure profiles because their alkaloid concentrations and formulations differ.
How do researchers measure mitragynine concentrations?
Researchers commonly use liquid chromatography-tandem mass spectrometry (LC-MS/MS) to quantify mitragynine and its metabolites in biological samples such as blood plasma.
